ĐIỀU TRỊ TĂNG HUYẾT áp rối LOẠN LIPID máu ở BỆNH NHÂN gút

U TR T ÁP & RI LON LIPID MÁU  BNH NHÂN GÚT

Mai Thị Minh Tâm






                 
-
-

allopurin








(theo Ward. Lancet 1998:352: 670-1)

-  HypoxanthineXanthine (Allopurinol,
Febuxostat)
- 
Fenofibrate )
- 




- Febuxostat
- Allopurinol.

- Losartan
- Fenofibrate.
Oxy hóa acide uric thành allantoine.



R


R







       n

R
).






             

 



                

Nghiên 

ofibrate
   -          

                  
         



T
1. Bardin T (2003), Fenofibrate and losartan. Ann Rheum Dis, 62:497-498
2. Becker MA, Jolly M (2006). Hyperuricemia and associated diseases. Rhem Dis Clin
North Am; 32:275-293.
3. Choi HK, Curhan G (2004). Alcohol intake and risk of incident gout in men: A
prospective study. Lancet, 363:1277-81
4. H.Bennesser Alaoui, Z Tazi Mezalek, H.Harmouche, A.Maaouni (2010). La goutte:
nouvelles recommandations. Espérance Médicale, 17(166), 119-133.
5. Hepburn AL, Kaye SA, Feher MD (2003), Long-term remission from gout associated
with fenofibrate therapy. Clin Rheumatol, 22:736.
6. Takahashi S, Moriwaki Y, Yamamoto T, Tsutsumi Z, Kufuchi M (2003), Effects of

combination treatment using antihyperuricaemic agents with fenofibrate and/or losartan
on uric acid metabolism. Ann Rheum Dis; 62:5725.
7. Würzner GC, Gersterb JC, Chiolero A, Maillard M, Fallab-Stubi CL, Brunner HS, et al
(2001). Comparative effects of losartan and irbesartan on serum uric acid in
hypertensive patients with hyperuricaemia and gout. J Hypertens;19:185560.
8. Yamamoto T, Moriwaki Y, Takahashi S, Tsutsumi Z, Hada T (2001). Effect of
fenofibrate on plasma concentration and urinary excretion of purine bases and
oxypurinol. J Rheumatol; 28:22947.
9. Elsaf M, Tsichodimos V, Bairaktari E, Siamopoulos KC (1999). Effect of micronized
fenofibrate and losartan combination on uric acid metabolism in hypertensive patients
with hyperuricemia. J Cardiovasc Pharmacol; 34:603.